- Info
- Insider Trading
- Financials
- Holders: XFOR, XFOR
X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share (XFOR)
CUSIP: 98420X103
Q3 2021 13F Holders as of 30 Sep 2021
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 7,938,059
- Total 13F shares
- 16,206,198
- Share change
- -380,704
- Total reported value
- $85,726,624
- Put/Call ratio
- 15%
- Price per share
- $5.29
- Number of holders
- 48
- Value change
- -$2,862,733
- Number of buys
- 14
- Number of sells
- 34
Quarterly Holders Quick Answers
What is CUSIP 98420X103?
CUSIP 98420X103 identifies XFOR - X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 98420X103:
Top shareholders of XFOR - X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Ikarian Capital, LLC |
13F
|
Company |
34%
|
2,719,290
|
$17,676,000 | — | 30 Jun 2021 | |
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
27%
|
2,119,540
|
$13,777,000 | — | 30 Jun 2021 | |
| AIGH Capital Management LLC |
13F
|
Company |
18%
|
1,438,899
|
$9,353,000 | — | 30 Jun 2021 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
17%
|
1,373,849
|
$8,930,000 | — | 30 Jun 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
11%
|
897,641
|
$5,834,000 | — | 30 Jun 2021 | |
| BVF INC/IL |
13F
|
Company |
11%
|
847,879
|
$5,511,000 | — | 30 Jun 2021 | |
| Sio Capital Management, LLC |
13F
|
Company |
10%
|
804,597
|
$5,230,000 | — | 30 Jun 2021 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
10%
|
795,312
|
$5,170,000 | — | 30 Jun 2021 | |
| Monashee Investment Management LLC |
13F
|
Company |
7.2%
|
574,712
|
$3,736,000 | — | 30 Jun 2021 | |
| AXA S.A. |
13F
|
Company |
7.2%
|
568,416
|
$3,695,000 | — | 30 Jun 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
4.9%
|
386,007
|
$2,509,000 | — | 30 Jun 2021 | |
| New Leaf Venture Partners, L.L.C. |
13F
|
Company |
4.2%
|
335,000
|
$2,178,000 | — | 30 Jun 2021 | |
| Worth Venture Partners, LLC |
13F
|
Company |
4.2%
|
334,684
|
$2,175,000 | — | 30 Jun 2021 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
4.1%
|
328,209
|
$2,133,000 | — | 30 Jun 2021 | |
| Polaris Venture Management Co. V, L.L.C. |
13F
|
Company |
3.9%
|
311,492
|
$2,025,000 | — | 30 Jun 2021 | |
| SV Health Investors, LLC |
13F
|
Company |
3.9%
|
311,490
|
$2,025,000 | — | 30 Jun 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.3%
|
263,290
|
$1,711,000 | — | 30 Jun 2021 | |
| Abingworth LLP |
13F
|
Company |
2.9%
|
229,885
|
$1,494,000 | — | 30 Jun 2021 | |
| FMR LLC |
13F
|
Company |
2.7%
|
212,620
|
$1,382,000 | — | 30 Jun 2021 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
2.2%
|
172,413
|
$1,082,000 | — | 30 Jun 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2%
|
161,917
|
$1,052,000 | — | 30 Jun 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.6%
|
130,694
|
$850,000 | — | 30 Jun 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.6%
|
125,297
|
$814,000 | — | 30 Jun 2021 | |
| Cormorant Asset Management, LP |
13F
|
Company |
1.3%
|
103,980
|
$676,000 | — | 30 Jun 2021 | |
| Prosight Management, LP |
13F
|
Company |
1.1%
|
87,813
|
$571,000 | — | 30 Jun 2021 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.9%
|
71,670
|
$466,000 | — | 30 Jun 2021 | |
| Endurant Capital Management LP |
13F
|
Company |
0.89%
|
70,969
|
$461,000 | — | 30 Jun 2021 | |
| Ergoteles LLC |
13F
|
Company |
0.88%
|
69,800
|
$454,000 | — | 30 Jun 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.86%
|
68,563
|
$446,000 | — | 30 Jun 2021 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.72%
|
56,893
|
$370,000 | — | 30 Jun 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.68%
|
54,007
|
$351,000 | — | 30 Jun 2021 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.64%
|
50,490
|
$328,000 | — | 30 Jun 2021 | |
| STATE STREET CORP |
13F
|
Company |
0.61%
|
48,480
|
$315,000 | — | 30 Jun 2021 | |
| Tibra Equities Europe Ltd |
13F
|
Company |
0.61%
|
48,400
|
$315,000 | — | 30 Jun 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.6%
|
47,334
|
$308,000 | — | 30 Jun 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.59%
|
47,073
|
$306,000 | — | 30 Jun 2021 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.49%
|
38,900
|
$253,000 | — | 30 Jun 2021 | |
| Bleichroeder LP |
13F
|
Company |
0.45%
|
35,730
|
$232,000 | — | 30 Jun 2021 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.36%
|
28,593
|
$186,000 | — | 30 Jun 2021 | |
| Trexquant Investment LP |
13F
|
Company |
0.32%
|
25,287
|
$164,000 | — | 30 Jun 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.28%
|
22,518
|
$147,000 | — | 30 Jun 2021 | |
| Engineers Gate Manager LP |
13F
|
Company |
0.27%
|
21,814
|
$142,000 | — | 30 Jun 2021 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.26%
|
20,638
|
$134,000 | — | 30 Jun 2021 | |
| Alpine Global Management, LLC |
13F
|
Company |
0.21%
|
16,877
|
$110,000 | — | 30 Jun 2021 | |
| BARCLAYS PLC |
13F
|
Company |
0.21%
|
16,410
|
$107,000 | — | 30 Jun 2021 | |
| Minot Wealth Management LLC |
13F
|
Company |
0.21%
|
17,000
|
$103,000 | — | 30 Jun 2021 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.17%
|
13,709
|
$89,000 | — | 30 Jun 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.17%
|
13,231
|
$86,000 | — | 30 Jun 2021 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.17%
|
13,135
|
$85,000 | — | 30 Jun 2021 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0.13%
|
10,350
|
$67,000 | — | 30 Jun 2021 |
Institutional Holders of X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share (XFOR) as of Q3 2021
As of 30 Sep 2021,
X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share (XFOR) was held by
48 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,206,198 shares.
The largest 10 holders included
Ikarian Capital, LLC, Bain Capital Life Sciences Investors, LLC, AIGH Capital Management LLC, ORBIMED ADVISORS LLC, VANGUARD GROUP INC, BVF INC/IL, Altium Capital Management LP, Sio Capital Management, LLC, AXA S.A., and Monashee Investment Management LLC.
This page lists
48
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
58
Q3 2021 holders
48
Holder diff
-10
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 Value $ | Q3 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.